Use of hormone therapies in disseminated carcinomatosis of the bone marrow associated with hormone receptor-positive breast cancer

被引：3

作者：

Ota, Takayo ^{[1
]}

Miyatake, Nozomi ^{[1
]}

Tanaka, Noriko ^{[2
]}

Hasegawa, Yoshikazu ^{[1
]}

Tokunaga, Masahiro ^{[2
]}

Tsukuda, Hiroshi ^{[1
]}

Fukuoka, Masahiro ^{[1
]}

机构：

[1] Izumi Municipal Hosp, Dept Med Oncol, 4-10-10 Fuchu, Izumi, Osaka 5940071, Japan

[2] Izumi Municipal Hosp, Dept Radiol, Izumi, Osaka, Japan

来源：

GYNECOLOGICAL ENDOCRINOLOGY | 2018年 / 34卷 / 04期

关键词：

Breast cancer; disseminated carcinomatosis of the bone marrow; hormone therapy; zoledronic acid; GASTRIC-CANCER; METASTASIS; PROGNOSIS;

D O I：

10.1080/09513590.2017.1393063

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Disseminated carcinomatosis of the bone marrow (DCBM) is diffusely invasive bone metastasis resulting from solid tumors. DCBM is often associated with disseminated intravascular coagulation (DIC) or hemolytic anemia. Generally, DCBM treatment includes cytotoxic chemotherapy for underlying solid tumors and management of hematological conditions if present. We report a case of DCBM accompanied with DIC in hormone receptor-positive breast cancer. Due to her life-threatening condition, we used hormone therapies, not cytotoxic chemotherapies, to treat her DCBM. With zoledronic acid, her DIC and general condition gradually improved and eventually she could return to her daily life. If DCBM occurs in hormone receptor-positive breast cancer, hormone therapy can be one of the treatment choices.

引用

页码：286 / 289

页数：4

共 50 条

[31] Differential impact of prognostic parameters in hormone receptor-positive lobular breast cancer [J].

Christgen, Matthias ;

Gluz, Oleg ;

Harbeck, Nadia ;

Kates, Ronald E. ;

Raap, Mieke ;

Christgen, Henriette ;

Clemens, Michael ;

Malter, Wolfram ;

Nuding, Benno ;

Aktas, Bahriye ;

Kuemmel, Sherko ;

Reimer, Toralf ;

Stefek, Andrea ;

Krabisch, Petra ;

Just, Marianne ;

Augustin, Doris ;

Graeser, Monika ;

Baehner, Frederick ;

Wuerstlein, Rachel ;

Nitz, Ulrike ;

Kreipe, Hans .

CANCER, 2020, 126 (22) :4847-4858

[32] Hormone receptor-positive breast cancer and black race: does sex matter? [J].

Mariam F. Eskander ;

Yaming Li ;

Oindrila Bhattacharyya ;

Allan Tsung ;

Bridget A. Oppong ;

Ahmad Hamad ;

Margaret Gatti-Mays ;

Samilia Obeng-Gyasi .

Breast Cancer Research and Treatment, 2021, 190 :111-119

[33] Pharmacologic management of bone-related complications and bone metastases in postmenopausal women with hormone receptor-positive breast cancer [J].

Yardley, Denise A. .

BREAST CANCER-TARGETS AND THERAPY, 2016, 8 :73-82

[34] Optimal Treatment of Hormone Receptor-positive Advanced Breast Cancer Patients With Palbociclib [J].

Morita, Midori ;

Ooe, Asako ;

Ishii, Wataru ;

Watanabe, Akira ;

Matsui, Chise ;

Okuyama, Yuka ;

Kitano, Sae ;

Kato, Chikage ;

Onishi, Mie ;

Sakaguchi, Koichi ;

Naoi, Yasuto .

ANTICANCER RESEARCH, 2023, 43 (06) :2783-2789

[35] Hormone receptor-positive early breast cancer in young women: A comprehensive review [J].

Walbaum, Benjamin ;

Garcia-Fructuoso, Isabel ;

Martinez-Saez, Olga ;

Schettini, Francesco ;

Sanchez, Cesar ;

Acevedo, Francisco ;

Chic, Nuria ;

Munoz-Carrillo, Javier ;

Adamo, Barbara ;

Munoz, Montserrat ;

Partridge, Ann H. ;

Bellet, Meritxell ;

Braso-Maristany, Fara ;

Prat, Aleix ;

Vidal, Maria .

CANCER TREATMENT REVIEWS, 2024, 129

[36] Checkpoint inhibition for early-stage hormone receptor-positive breast cancer [J].

Schlam, Ilana ;

Corti, Chiara ;

Sammons, Sarah ;

Mittendorf, Elizabeth A. ;

Tolaney, Sara M. .

EXPERT OPINION ON BIOLOGICAL THERAPY, 2024, 24 (06) :511-520

[37] Disseminated carcinomatosis of the bone marrow from gastric cancer during pregnancy [J].

Kinoshita, Shotaro ;

Yamashita, Kohei ;

Iwatsuki, Masaaki ;

Sato, Hiroki ;

Matsumoto, Chihiro ;

Matsumoto, Takashi ;

Shiraishi, Yuta ;

Yoshida, Naoya ;

Baba, Hideo .

CLINICAL JOURNAL OF GASTROENTEROLOGY, 2019, 12 (05) :447-452

[38] Impact of FOXA1 Expression on the Prognosis of Patients with Hormone Receptor-Positive Breast Cancer [J].

Yuichi Hisamatsu ;

Eriko Tokunaga ;

Nami Yamashita ;

Sayuri Akiyoshi ;

Satoko Okada ;

Yuichiro Nakashima ;

Shinichi Aishima ;

Masaru Morita ;

Yoshihiro Kakeji ;

Yoshihiko Maehara .

Annals of Surgical Oncology, 2012, 19 :1145-1152

[39] The Prognosis of Single Hormone Receptor-Positive Breast Cancer Stratified by HER2 Status [J].

Zhao, Hengqiang ;

Gong, Yiping .

FRONTIERS IN ONCOLOGY, 2021, 11

[40] Novel Estrogen Receptor - Targeted Therapies in Hormone-Receptor Positive Breast Cancer [J].

Neill, Nina E. ;

Mauro, Lauren A. ;

Pennisi, Angela .

CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2025, 26 (04) :302-312

← 1 2 3 4 5 →